<DOC>
	<DOCNO>NCT00002210</DOCNO>
	<brief_summary>The purpose study see safe effective give delavirdine mesylate ( Rescriptor ) plus two nucleoside reverse transcriptase inhibitor ( NRTIs ) HIV-infected child baby . This study also examine body process Rescriptor take 2 NRTIs .</brief_summary>
	<brief_title>A Study Delavirdine Mesylate Combination With Other Anti-HIV Drugs HIV-Infected Children Babies</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Delavirdine</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . Plasma HIV1 level great 10,000 copies/ml .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 1998</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Delavirdine</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
</DOC>